Indeed, steroid hormone receptors including androgen receptor (AR) are members of a superfamily of ligand-activated transcription factors that are potentially oncogenic in gliomas as has been proposed by other researchers (17, 18) and has been confirmed in prostate cancer (19). This evidence concerns the gene AR and central nervous system cancer.